ð¬ Current Disease Focus:
Task Progress: 0%
ð¥ Active Problem Solvers
0
ð Experts collaborating globally
â¡ Current Task Assignment
𧬠Genetic Analysis
ð Matching experts to specific tasks
ð Resource Allocation by Research Phase:
ð Data Analysis
𧪠Experimental Design
ð¬ Clinical Trials
ð Treatment Development
Aumolertinib is a third-generation epidermal growth factor receptor (EGFR) ...
Status
Terminated
Location
Highlands Oncology Group
Start Date
2022-12-14
Trial ID
NCT05493501
HS-10241, an oral and highly selective MET-TKI, may contribute to overcomin...
Status
Unknown
Location
Multiple Locations
Start Date
2023-12-30
Trial ID
NCT06110663
Treatments Being Tested
The goal of this observational study is to extract the imaging features of ...
Status
Recruiting
Location
Shanghai Cancer center
Start Date
2024-09-30
Trial ID
NCT06604689
Treatments Being Tested
The goal of this observational study is to explore the feasibility of stere...
Status
Completed
Location
Wuhan Tongji Hospital
Start Date
2018-09-01
Trial ID
NCT06613633
Treatments Being Tested
The study is being conducted to evaluate the safety and tolerability of HRS...
Status
Terminated
Location
Zhejiang Cancer Hospital
Start Date
2021-10-25
Trial ID
NCT05048134
Treatments Being Tested
Efficacy and safety of postoperative adjuvant treatment of NSCLC patients w...
Status
Unknown
Location
Shanghai Chest Hospital
Start Date
2022-01-14
Trial ID
NCT04922138
Treatments Being Tested